Design and Analysis of Phase II Trials in Oncology

March 31, 2011

IDDI organized a webinar on DESIGN AND ANALYSIS OF PHASE II TRIALS IN ONCOLOGY.

This webinar presented key concepts and current examples regarding the design and analysis of phase II trials in oncology. Aims, methods and limitations of phase II trials in oncology, including the important issues of study design, choice of endpoints, the need for randomization, and correct interpretation and decisions in the overall drug-development process.

 VIEW THE RECORDING OF THE WEBINAR HERE

TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR, PLEASE FILL OUT THE FORM BELOW

Design and Analysis of Phase II Trials in Oncology

To access the presentation of this on-demand webinar, register to the right
  • This webinar presented key concepts and current examples regarding the design and analysis of phase II trials in oncology.
  • Speakers:
    • Marc Buyse, ScD, Chief Scientific Officer, IDDI
      • Marc Buyse holds a ScD in biostatistics from the Harvard School of Public Health (Boston, MA). He is the founder of the International Drug Development Institute (IDDI) and of CluePoints, two biostatistical service organizations based in the US and Europe. He is interested in clinical trial design, meta-analysis, validation of biomarkers and surrogate endpoints, statistical methods in oncology, statistical detection of errors and fraud, statistical monitoring of clinical trials, and medical data sharing (http://publicationslist.org/marc.buyse)
    • Dr. Everardo Saad, MD,Senior Medical Expert,  IDDI
      • Dr. Saad, IDDI’s Senior Medical Expert, has over 15 years of experience in Medical Oncology and clinical trial designs. He graduated in Medicine and trained in Internal Medicine in Sao Paulo, and did his fellowship in Medical Oncology at the University of Texas M.D. Anderson Cancer Center, in Houston. After practicing for several years, he shifted his professional career towards education and research in Medical Oncology, and has a special interest in clinical trial methodology, the assessment of endpoints, and the development of novel therapies for cancer patients.

Presentation of the Webinar: Design and Analysis of Phase II Trials in Oncology

To access the presentation of this on-demand webinar, please fill out this form.

By submitting this form, you agree to receiving commercial electronic messages such as e-mails from IDDI. For more info, please visit our Privacy Policy. You can unsubscribe at any time by clicking the 'unsubscribe' button at the foot of any e-mail communication from IDDI.

I authorize IDDI to use my data to contact me for commercial purposes. More information
Powered by Atypic ®

IDDI